Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLITION: Circulating Nucleosomes in Non-Hodgkin Lymphoma
NCT06813573Active, not recruiting
- Sponsor
- Gustave Roussy
- Start
- Sep 2024
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Gustave Roussy. Primary endpoint: Prospective quantitative analysis of the level of circulating nucleosomes up to 24 months. Started Sep 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06813573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06813573.